By using models of MDS and examining the proteome of primary MDS HSPCs, we observed the loss of NPM1 regulation by the SCF-FBXO11 complex and show that this underlies the poor prognostic features of MDS progression. Here, FBXO11 is linked to myelodysplastic syndrome.